Compounds > triazoles
Page last updated: 2024-08-24

triazoles and Small Cell Lung Carcinoma

triazoles has been researched along with Small Cell Lung Carcinoma in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (8.33)29.6817
2010's10 (83.33)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Bie, Z; Chen, J; Dong, Z; Huang, D; Jiang, R; Jiang, X; Li, L; Li, M; Lin, L; Liu, Z; Meng, Z; Qin, T; Sun, T; Wang, J; Wang, L; Yang, G; Yu, J; Zhang, C; Zhang, M; Zhang, Y1
Adeegbe, DO; Bradner, JE; Buczkowski, K; Chen, T; Christensen, CL; Dries, R; Gao, P; Hammerman, PS; Han, S; Li, F; Li, Y; Liu, S; Liu, Y; Quayle, SN; Quinn, MM; Wang, X; Wong, KK; Zhang, H1
Cobb, MH; Ding, Q; Hu, R; Huffman, KE; Johnson, JE; Minna, JD; Savage, TK; Wang, XD; Williams, N; Yu, Y1
Essenburg, C; Kaufman, D; Lewis, S; Staal, B; Vande Woude, GF; Zhang, YW1
Alberobello, AT; Giaccone, G; Lai, CH; Lee, DH; Park, KS; Petricoin Iii, EF; Pierobon, M; Pin, E; Raffeld, M; Wang, Y1
Baxi, SM; Estrella, H; Li, C; Liu, KK; Mehta, PP; Smeal, T; Walls, M; Yin, MJ; Zhu, J; Zientek, M; Zong, Q1
Yaqub, F1
Cao, J; Desilva, H; Fairchild, C; Johnston, K; Kirov, S; Lei, M; Lenhart, R; Peterson, R; Purandare, A; Ross-Macdonald, P; Schweizer, L; Wee, S; Wong, T1
Alibés, A; Fiorentino, FP; Kato, F; Kohno, T; Perucho, M; Sánchez-Céspedes, M; Yokota, J1
Giaccone, G; Subramaniam, DS; Warner, EA1
Choe, DH; Kang, MS; Kim, CH; Lee, JC; Noh, GY1
Ford, SJ; Jansson, PJ; Kalinowski, DS; Kovacevic, Z; Lovejoy, DB; Lui, GY; Obeidy, P; Richardson, DR; Sharp, DM; Tselepis, C1

Reviews

1 review(s) available for triazoles and Small Cell Lung Carcinoma

ArticleYear
Ganetespib for small cell lung cancer.
    Expert opinion on investigational drugs, 2017, Volume: 26, Issue:1

    Topics: Animals; Antineoplastic Agents; HSP90 Heat-Shock Proteins; Humans; Lung Neoplasms; Molecular Weight; Small Cell Lung Carcinoma; Triazoles; Up-Regulation

2017

Other Studies

11 other study(ies) available for triazoles and Small Cell Lung Carcinoma

ArticleYear
XPO1 inhibition synergizes with PARP1 inhibition in small cell lung cancer by targeting nuclear transport of FOXO3a.
    Cancer letters, 2021, 04-10, Volume: 503

    Topics: Active Transport, Cell Nucleus; Animals; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Cytoplasm; Drug Synergism; Exportin 1 Protein; Female; Forkhead Box Protein O3; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Karyopherins; Lung Neoplasms; Mice; Phthalazines; Receptors, Cytoplasmic and Nuclear; Small Cell Lung Carcinoma; Triazoles; Xenograft Model Antitumor Assays

2021
NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model.
    Cancer research, 2018, 07-01, Volume: 78, Issue:13

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azepines; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Histone Deacetylase 6; Humans; Hydroxamic Acids; Killer Cells, Natural; Lung Neoplasms; Mice; Neoplasm Recurrence, Local; Proteins; Pyrimidines; RNA, Small Interfering; Small Cell Lung Carcinoma; Synthetic Lethal Mutations; Treatment Outcome; Triazoles; Xenograft Model Antitumor Assays

2018
Subtype-specific secretomic characterization of pulmonary neuroendocrine tumor cells.
    Nature communications, 2019, 07-19, Volume: 10, Issue:1

    Topics: Animals; Azepines; Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Insulin-Like Growth Factor Binding Protein 5; Lung Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms, Experimental; Neuroendocrine Tumors; Octamer Transcription Factors; Proteomics; Pyrazoles; Receptor, IGF Type 1; Signal Transduction; Small Cell Lung Carcinoma; Transcription Factors; Triazines; Triazoles

2019
Strengthening context-dependent anticancer effects on non-small cell lung carcinoma by inhibition of both MET and EGFR.
    Molecular cancer therapeutics, 2013, Volume: 12, Issue:8

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Mice; Molecular Targeted Therapy; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyridazines; Quinazolines; Signal Transduction; Small Cell Lung Carcinoma; Triazoles; Xenograft Model Antitumor Assays

2013
HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer.
    Oncogene, 2014, Oct-02, Volume: 33, Issue:40

    Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Synergism; G2 Phase Cell Cycle Checkpoints; HSP90 Heat-Shock Proteins; Humans; Inhibitory Concentration 50; Lung Neoplasms; Mice; Mice, Nude; Small Cell Lung Carcinoma; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays

2014
Targeting small cell lung cancer harboring PIK3CA mutation with a selective oral PI3K inhibitor PF-4989216.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Feb-01, Volume: 20, Issue:3

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Class I Phosphatidylinositol 3-Kinases; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Immunoblotting; Lung Neoplasms; Mice; Mice, SCID; Mutation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Small Cell Lung Carcinoma; Thiophenes; Triazoles; Xenograft Model Antitumor Assays

2014
American Society of Clinical Oncology Annual Meeting 2013.
    The Lancet. Respiratory medicine, 2013, Volume: 1, Issue:5

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Docetaxel; Erlotinib Hydrochloride; Female; Humans; Imidazoles; Indoles; Lung Neoplasms; Male; Medical Oncology; Multicenter Studies as Topic; Oximes; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinazolines; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Societies, Medical; Sulfones; Sunitinib; Taxoids; Treatment Outcome; Triazoles; United States

2013
Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene Expression.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:10

    Topics: Antineoplastic Agents; Azepines; Basic Helix-Loop-Helix Transcription Factors; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enhancer Elements, Genetic; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Lung Neoplasms; Nuclear Proteins; Protein Binding; Small Cell Lung Carcinoma; Transcription Factors; Transcriptome; Triazoles

2015
MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells.
    Oncotarget, 2016, Nov-22, Volume: 7, Issue:47

    Topics: Antineoplastic Agents; Apoptosis; Azepines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 6; Drug Resistance, Neoplasm; Gene Amplification; Gene Expression; Gene Expression Profiling; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-myc; Small Cell Lung Carcinoma; Transcriptome; Triazoles

2016
A newly developed lung nodule during chemotherapy for small cell lung cancer. Chronic necrotising pulmonary aspergillosis.
    Thorax, 2009, Volume: 64, Issue:8

    Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chronic Disease; Etoposide; Humans; Lung Neoplasms; Male; Pulmonary Aspergillosis; Pyrimidines; Small Cell Lung Carcinoma; Triazoles; Voriconazole

2009
The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of action.
    Molecular pharmacology, 2013, Volume: 83, Issue:1

    Topics: Administration, Oral; Animals; Antigens, CD; Antineoplastic Agents; Apoptosis; Benzoates; Cell Cycle; Cell Line, Tumor; Copper; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Deferasirox; Female; Humans; Iron; Iron Chelating Agents; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neuroectodermal Tumors, Primitive, Peripheral; Protein Serine-Threonine Kinases; Receptors, Transferrin; Small Cell Lung Carcinoma; Transplantation, Heterologous; Triazoles; Zinc

2013